#USA #Cambridge #Zifo #Pistoia Alliance #IVP Assay

Launch of the IVP Assay Repository

In a significant advancement for the life sciences industry, Zifo has officially announced the launch of the In Vitro Pharmacology (IVP) Assay Repository. This initiative, developed in collaboration with the Pistoia Alliance and leading pharmaceutical companies, aims to standardize the way biological assays are documented, shared, and reused, addressing long-standing challenges within the sector.

Importance of the Repository

For years, the life sciences industry faced challenges due to fragmented data concerning in vitro pharmacology, inconsistent documentation of assays, and limited interoperability across various organizations and platforms. This fragmentation created "data silos," making it difficult to efficiently exchange data, conduct comparative studies, and reuse assay information within the drug discovery and development ecosystem.

The newly launched IVP Assay Repository tackles these issues by establishing a structured framework that facilitates the registration and management of in vitro pharmacology assays in a consistent and transparent manner. This repository is a crucial resource designed to enhance collaboration among researchers and increase data quality across the board.

Collaborative Development Efforts

Zifo's development team, consisting of Scientific Informatics and Data experts, collaborated with regulatory authorities and members of the Pistoia Alliance to create this repository. Steering committee members hailed from renowned companies such as AbbVie, Novartis, Merck, and Roche, ensuring that the repository's design aligns with industry needs. Utilizing controlled vocabularies and standardized data fields, the repository builds upon established public ontologies, such as the Bioassay Ontology (BAO), to improve data quality and minimize redundancy in the biopharma ecosystem.

As Aishwarya Balajee, Head of Scientific Data and Digital at Zifo, stated, "Releasing version 1.0 of the IVP Assay Repository is a significant milestone. This platform promotes a more open and interoperable future for biological data, allowing the industry to effectively describe, discover, and reuse assays across different organizations."

Features and Benefits

The IVP Assay Repository offers several key features and benefits, including:

• - Enhanced Data Exchange and Interoperability: A centralized repository improves assay discoverability, consistency in documentation, and interoperability across various platforms and organizations.
• - Facilitated Collaboration: By encouraging cross-sector collaboration between biopharma companies, CROs, technology providers, and regulatory stakeholders, the repository promotes a common framework for sharing assay information.
• - Informatics Excellence: Leveraging Zifo’s expertise, the repository provides a guided interface that enables users to easily search, filter, and contribute new assay entries, covering design, targets, and molecular details.

Open for Community Feedback

With the release of its first version, the IVP Assay Repository is now accessible to the broader life sciences community, inviting feedback to improve its governance models and usage frameworks. As the repository evolves, it will continue to adapt to the needs of researchers, data scientists, organizations, and regulators.

For additional insights about the project and the future of biological assay standardization, visit the Pistoia Alliance website.

Who is Zifo?

Zifo is renowned as a global leader in providing AI-driven data solutions and enterprise informatics across various science-based industries. Offering extensive service expertise spanning research, development, and manufacturing domains, Zifo serves a diverse array of sectors—including Pharma, Biotech, Chemicals, Food and Beverage, Oil and Gas, and FMCG.

About the Pistoia Alliance

The Pistoia Alliance is an international nonprofit organization comprised of life science companies, technology and service providers, and academic groups committed to reducing barriers to innovation within the R&D landscape. Their collaborative efforts greatly enhance the efficiency of research and development processes.

In conclusion, the launch of the IVP Assay Repository marks a pivotal step in transforming the way biological assays are handled within the life sciences sector, paving the way for enhanced collaboration and innovative advancements.